Definitive Contract HHSO100201500004C
Award Date 3/23/15
Potential Completion Date 7/31/19
Potential Value $44M
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit manufacturer of medical countermeasures. The $1,174,464,339.10 firm fixed-price contract is for the production of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. The...
- This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency under the Department of Health and Human Services (HHS), to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The $196,434,000 award is for the provision of anthrax antitoxins to treat inhalational anthrax, under the agency's medical countermeasures development and procurement program. The...
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Emergent Product Development Gaithersburg Inc. a firm fixed price contract valued at $804.9 million on August 30, 2019, for the manufacture and delivery of ACAM2000, a live vaccinia smallpox vaccine. The contract, which extends through August 29, 2029, supports the federal government's medical countermeasures stockpiling and pandemic preparedness initiatives. Work will be...
- The Biomedical Advanced Research and Development Authority (BARDA), operating under the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, awarded a definitive firm fixed price contract to Emergent Product Development Gaithersburg Inc. valued at approximately $1.53 billion. This no-cost modification updates contract articles for the development of medical countermeasures targeting filovirus outbreaks, which are identified as critical...
- The U.S. Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Emergent Biodefense Operations Lansing LLC a $66.9 million firm fixed-price delivery order on January 4, 2026, for the procurement of BioThrax (Anthrax Vaccine Absorbed). The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2029, with manufacturing and delivery operations based in Lansing, Michigan. This delivery order is issued under an...
- This is a $30,559,760.00 cost-plus-fixed-fee delivery order awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The contract is for the development of the MAPP biopharmaceutical Viral Hemorrhagic Fever (VHF) Medical Countermeasure (MCM) platform. This work is being performed under the Centers for Innovation in...
- This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, with a ceiling value of $86,670,401.90, is for biomedical (advanced) products and services. The prime contractor is Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization. The contract does not have a set-aside designation and has an ultimate completion date...
- The Office of the Assistant Secretary for Preparedness and Response awarded a $124.5 million firm fixed-price definitive contract to Elusys Therapeutics Inc. on May 1, 2024, for the supply and delivery of ANTHIM (obiltoxaximab), a monoclonal antitoxin therapeutic. The contract, which extends through December 31, 2028, is being performed at the contractor's facility in Parsippany, New Jersey. This award reflects the federal government's commitment to maintaining strategic medical...
- This is a firm-fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Elusys Therapeutics Inc., a self-certified small disadvantaged business. The contract, valued at $24,501,100.00, is for "ANTHIM LETTER CONTRACT" and "FOR OTHER FUNCTIONS" services in the area of biomedical research and development. The contract has no set-aside designation and the period of...
- On March 13, 2019, the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services, awarded a firm fixed price purchase order to Emergent Product Development Gaithersburg Inc. for diluent replacement services. The contract carries a ceiling value of $12.2 million and is scheduled for completion by June 30, 2019. No set-aside designation was applied to this award, and work will be performed in Washington, DC....